Literature DB >> 15956405

Molecular epidemiology of community- and health care-associated methicillin-resistant Staphylococcus aureus in Manitoba, Canada.

John L Wylie1, Deborah L Nowicki.   

Abstract

Recently, acquisition of methicillin-resistant Staphylococcus aureus (MRSA) has been increasingly seen in community settings. Beginning in 1995, we have routinely conducted pulsed-field gel electrophoresis (PFGE) of MRSA isolates received at Cadham Provincial Laboratory (CPL) in Manitoba, Canada. Our diverse collection of isolates coupled with molecular subtype information allowed us to assess the extent to which MRSA isolates in general were associated with community acquisition and whether specific PFGE types were more likely to be found in community settings. Forty percent of the MRSA isolates in our analysis were designated community associated (CA), with two of the six most common PFGE types showing a greater likelihood to be CA-MRSA. Overall, CA-MRSA were more likely to show multiple sensitivity to antibiotics and to be associated with younger age groups. Mapping of specific CA-MRSA types over successive 5-year periods showed rapid temporal shifts in prevalence in different parts of the province.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15956405      PMCID: PMC1151926          DOI: 10.1128/JCM.43.6.2830-2836.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis.

Authors:  M R Mulvey; L Chui; J Ismail; L Louie; C Murphy; N Chang; M Alfa
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Laboratory characterization of methicillin-resistant Staphylococcus aureus in Canadian hospitals: results of 5 years of National Surveillance, 1995-1999.

Authors:  Andrew E Simor; Marianna Ofner-Agostini; Elizabeth Bryce; Allison McGeer; Shirley Paton; Michael R Mulvey
Journal:  J Infect Dis       Date:  2002-08-09       Impact factor: 5.226

3.  Intercontinental spread of a multidrug-resistant methicillin-resistant Staphylococcus aureus clone.

Authors:  M Aires de Sousa; I S Sanches; M L Ferro; M J Vaz; Z Saraiva; T Tendeiro; J Serra; H de Lencastre
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

4.  Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community.

Authors:  Keiko Okuma; Kozue Iwakawa; John D Turnidge; Warren B Grubb; Jan M Bell; Frances G O'Brien; Geoffrey W Coombs; John W Pearman; Fred C Tenover; Maria Kapi; Chuntima Tiensasitorn; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

Review 6.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

7.  Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory.

Authors:  G P Maguire; A D Arthur; P J Boustead; B Dwyer; B J Currie
Journal:  Med J Aust       Date:  1996-06-17       Impact factor: 7.738

8.  Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection.

Authors:  Timothy S Naimi; Kathleen H LeDell; Kathryn Como-Sabetti; Stephanie M Borchardt; David J Boxrud; Jerome Etienne; Susan K Johnson; Francois Vandenesch; Scott Fridkin; Carol O'Boyle; Richard N Danila; Ruth Lynfield
Journal:  JAMA       Date:  2003-12-10       Impact factor: 56.272

9.  Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children.

Authors:  Carlos A Sattler; Edward O Mason; Sheldon L Kaplan
Journal:  Pediatr Infect Dis J       Date:  2002-10       Impact factor: 2.129

Review 10.  Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones.

Authors:  Marta Aires de Sousa; Hermínia de Lencastre
Journal:  FEMS Immunol Med Microbiol       Date:  2004-03-08
View more
  18 in total

1.  Contamination of herbal medicinal products marketed in Kaduna metropolis with selected pathogenic bacteria.

Authors:  Danladi Abba; Helen I Inabo; Sabo E Yakubu; Olayeni S Olonitola
Journal:  Afr J Tradit Complement Altern Med       Date:  2008-10-25

2.  Development of a triplex real-time PCR assay for detection of Panton-Valentine leukocidin toxin genes in clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Ryan R McDonald; Nick A Antonishyn; Toni Hansen; Laelie A Snook; Evelyn Nagle; Michael R Mulvey; Paul N Levett; Greg B Horsman
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

3.  Community-associated MRSA: superbug at our doorstep.

Authors:  Michael Hawkes; Michelle Barton; John Conly; Lindsay Nicolle; Clare Barry; Elizabeth L Ford-Jones
Journal:  CMAJ       Date:  2007-01-02       Impact factor: 8.262

4.  Comparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus.

Authors:  Sara Christianson; George R Golding; Jennifer Campbell; Michael R Mulvey
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

5.  Antimicrobial resistance: An update from the Canadian Committee on Antibiotic Resistance.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

6.  Community-associated methicillin-resistant Staphylococcus aureus: Continuing to evolve.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

7.  Guidelines for the prevention and management of community-associated methicillin-resistant Staphylococcus aureus: A perspective for Canadian health care practitioners.

Authors:  Michelle Barton; Michael Hawkes; Dorothy Moore; John Conly; Lindsay Nicolle; Upton Allen; Nora Boyd; Joanne Embree; Liz Van Horne; Nicole Le Saux; Susan Richardson; Aideen Moore; Dat Tran; Valerie Waters; Mary Vearncombe; Kevin Katz; J Scott Weese; John Embil; Marianna Ofner-Agostini; E Lee Ford-Jones
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-09       Impact factor: 2.471

Review 8.  Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

Authors:  Michael Z David; Robert S Daum
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

9.  Role of SCCmec type in outcome of Staphylococcus aureus bacteremia in a single medical center.

Authors:  Roopa Ganga; Kathleen Riederer; Mamta Sharma; Mohamad G Fakih; Leonard B Johnson; Stephen Shemes; Riad Khatib
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

10.  Community-associated methicillin-resistant Staphylococcus aureus in northwest Ontario: A five-year report of incidence and antibiotic resistance.

Authors:  Jill Muileboom; Marsha Hamilton; Karen Parent; Donna Makahnouk; Michael Kirlew; Raphael Saginur; Freda Lam; Len Kelly
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.